Gemcitabine HCl | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Gemcitabine HCl
US Patents

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2025-11-03

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

pharmacompass-2-m-2025-11-03

Gemcitabine HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

100 API Suppliers, 29 USDMF, 26 CEP/COS, 13 JDMF, 9 EU WC, 30 KDMF, 18 NDC API, 46 Listed Suppliers, $ API Reference Price

100 API Suppliers
29 USDMF
26 CEP/COS
13 JDMF
9 EU WC
30 KDMF
18 NDC API
46 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

847 Drugs in Development

847 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

253 FDF Dossiers, 92 FDA Orange Book, 91 Europe, 4 Canada, 4 Australia, 22 South Africa, 40 Listed Dossiers

253 FDF Dossiers
92 FDA Orange Book
91 Europe
4 Canada
4 Australia
22 South Africa
40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 1 Kirsch Pharma, 1 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Gangwal Healthcare
1 Pfanstiehl
1 Kirsch Pharma
1 Actylis
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Direct Compression, 7 Disintegrants & Superdisintegrants, 6 Parenteral, 3 Co-Processed Excipients, 3 Granulation, 1 Solubilizers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
12 Chewable & Orodispersible Aids
10 Taste Masking
10 Direct Compression
7 Disintegrants & Superdisintegrants
6 Parenteral
3 Co-Processed Excipients
3 Granulation
1 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 116 News #PharmaBuzz

2 Data Compilation #PharmaFlow
116 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 52 Regulatory FDF Prices, 2 Annual Reports

10 US Medicaid Prescriptions
52 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

17 APIs, 9 FDF Dossiers, 2 Intermediates

17 APIs
9 FDF Dossiers
2 Intermediates

PATENTS & EXCLUSIVITIES

13 US Patents, 1 US Exclusivities

13 US Patents
1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

3 EDQM
5 Others

$ API Ref.Price (USD/KG) : 3,417 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

13 All

01 3JANSSEN BIOTECH

02 10SUN PHARM

filter Patent Number Reset all filters

13 All

01 18679094

02 109241948

03 110729823

04 112403086

API Patent Reset all filters

13 All

01 13Blank

filter FDF Patent Reset all filters

13 All

01 13Y

filter Expiration Date Reset all filters

13 All

01 12030-06-28

02 12032-04-15

03 102033-07-01

04 12034-08-19

Product Main Page

01

JANSSEN BIOTECH

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

JANSSEN BIOTECH

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-15

GEMCITABINE HYDROCHLORIDE

US Patent Number : 8679094

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219683

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

JANSSEN BIOTECH

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

JANSSEN BIOTECH

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-08-19

GEMCITABINE HYDROCHLORIDE

US Patent Number : 10729823

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219683

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-08-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

JANSSEN BIOTECH

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

JANSSEN BIOTECH

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-28

GEMCITABINE HYDROCHLORIDE

US Patent Number : 12403086

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219683

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

SUN PHARM

GEMCITABINE HYDROCHLORIDE

AAPS

Not Confirmed

SUN PHARM

AAPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!